These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors. Cussenot O; Villette JM; Cochand-Priollet B; Berthon P Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663 [TBL] [Abstract][Full Text] [Related]
4. Chromogranin A gene expression in non-small cell lung carcinomas. Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430 [TBL] [Abstract][Full Text] [Related]
5. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum. Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522 [TBL] [Abstract][Full Text] [Related]
6. The chromogranin-A (CgA) in prostate cancer. Ranno S; Motta M; Rampello E; Risino C; Bennati E; Malaguarnera M Arch Gerontol Geriatr; 2006; 43(1):117-26. PubMed ID: 16280180 [TBL] [Abstract][Full Text] [Related]
7. Chromogranin A and pancreastatin-like immunoreactivity in normal pregnancies. Syversen U; Opsjøn SL; Stridsberg M; Sandvik AK; Dimaline R; Tingulstad S; Arntzen KJ; Brenna E; Waldum HL J Clin Endocrinol Metab; 1996 Dec; 81(12):4470-5. PubMed ID: 8954061 [TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine differentiation in carcinomas of the prostate: do neuroendocrine serum markers reflect immunohistochemical findings? Angelsen A; Syversen U; Haugen OA; Stridsberg M; Mjølnerød OK; Waldum HL Prostate; 1997 Jan; 30(1):1-6. PubMed ID: 9018329 [TBL] [Abstract][Full Text] [Related]
9. Elevated serum chromogranin A is detectable in patients with carcinomas at advanced disease stages. Wu JT; Erickson AJ; Tsao KC; Wu TL; Sun CF Ann Clin Lab Sci; 2000 Apr; 30(2):175-8. PubMed ID: 10807161 [TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance. Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941 [TBL] [Abstract][Full Text] [Related]
11. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344 [TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine markers; chromogranin, pancreastatin and serotonin in the management of patients with advanced renal cell carcinoma. Edgren M; Stridsberg M; Kalknar KM; Nilsson S Anticancer Res; 1996; 16(6B):3871-4. PubMed ID: 9042273 [TBL] [Abstract][Full Text] [Related]
14. [Detection of neuroendocrine differentiation in NSCLC and its clinical significance]. Ouyang N; Chen G; Ding J Zhonghua Jie He He Hu Xi Za Zhi; 2001 Feb; 24(2):90-2. PubMed ID: 11802946 [TBL] [Abstract][Full Text] [Related]
15. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Gazdar AF; Helman LJ; Israel MA; Russell EK; Linnoila RI; Mulshine JL; Schuller HM; Park JG Cancer Res; 1988 Jul; 48(14):4078-82. PubMed ID: 3383200 [TBL] [Abstract][Full Text] [Related]
16. Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia. Syversen U; Jacobsen MB; O'Connor DT; Rønning K; Waldum HL Neuropeptides; 1994 Mar; 26(3):201-6. PubMed ID: 8208366 [TBL] [Abstract][Full Text] [Related]
17. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease. Berruti A; Mosca A; Tucci M; Terrone C; Torta M; Tarabuzzi R; Russo L; Cracco C; Bollito E; Scarpa RM; Angeli A; Dogliotti L Endocr Relat Cancer; 2005 Mar; 12(1):109-17. PubMed ID: 15788643 [TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study. Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064 [TBL] [Abstract][Full Text] [Related]